Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9900
+0.0091 (0.93%)
At close: Oct 28, 2026, 4:00 PM EDT
0.9784
-0.0116 (-1.17%)
After-hours: Oct 28, 2026, 4:12 PM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $19.07 million as of October 28, 2026. It is the 37,199th most valuable company in the world and the 5,221st biggest in the United States. Its market cap has increased by 51.35% in one year.
Market Cap
19.07M
Enterprise Value
18.24M
1-Year Change
51.35%
Global Rank
Country Rank
#5,221 United States
Category
ChartMarket Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $19.07M, a decrease of -83.46%. That is a compound annual growth rate of -18.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 19.10M | 41.48% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 21.56M |
| Polyrizon | 20.84M |
| Quantum BioPharma | 19.65M |
| Akari Therapeutics, | 19.61M |
| Quoin Pharmaceuticals | 19.46M |
| BeyondSpring | 19.00M |
| Neuphoria Therapeutics | 18.34M |
| Kyntra Bio | 18.22M |